Description
BSE announces listing of two series of Commercial Papers issued by Julius Baer Capital (India) Private Limited on private placement basis, effective November 10, 2025.
Summary
BSE has listed two series of Commercial Papers issued by Julius Baer Capital (India) Private Limited on private placement basis, effective November 10, 2025. Both instruments are rated CRISIL A1+ and ICRA A1+ with face value of Rs. 5,00,000 each and will be traded only in dematerialized form. HDFC Bank Limited serves as the Issuing and Paying Agent.
Key Points
- Two series of Commercial Papers listed on BSE Debt segment
- Series 1 (Scrip Code 730525, ISIN INE824H14SU3): 3,000 units with redemption on February 9, 2026
- Series 2 (Scrip Code 730526, ISIN INE824H14SS7): 3,000 units with redemption on June 10, 2026
- Face value and paid-up value: Rs. 5,00,000 per unit for both series
- Issue prices: Rs. 4,91,628.50 (Series 1) and Rs. 4,79,929.50 (Series 2)
- Credit rating: CRISIL A1+ and ICRA A1+ for both instruments
- Trading in dematerialized form only with market lot of 1
- Tick size: 1 paise
Regulatory Changes
No regulatory changes introduced.
Compliance Requirements
- Trading members must trade these securities only in dematerialized form under the specified ISIN numbers
- Trading shall take place in standard denomination of Rs. 5 lakhs and multiples thereof
- Securities must be traded with tick size of 1 paise
Important Dates
- Allotment date: November 10, 2025 (both series)
- Listing effective date: November 10, 2025
- Redemption date (Series 1 - JBC101125): February 9, 2026
- Redemption date (Series 2 - JBCI101125): June 10, 2026
Impact Assessment
This is a routine administrative notice with minimal market impact. The listing of commercial papers on private placement basis affects only specific institutional investors and does not have broader implications for retail markets. The securities are short-term debt instruments with tenure of approximately 3-7 months and are limited to institutional trading in Rs. 5 lakh denominations.
Impact Justification
Routine listing notice for commercial paper on private placement basis with no broad market impact